Last reviewed · How we verify

Antithrombotic Agent — Competitive Intelligence Brief

Antithrombotic Agent (Antithrombotic Agent) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antithrombotic Agent. Area: Cardiovascular.

marketed Antithrombotic Agent Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Antithrombotic Agent (Antithrombotic Agent) — Oslo University Hospital. Antithrombotic agents prevent blood clot formation by inhibiting platelet aggregation or coagulation cascade pathways.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Antithrombotic Agent TARGET Antithrombotic Agent Oslo University Hospital marketed Antithrombotic Agent
Conventional antithrombotic strategy Conventional antithrombotic strategy Duk-Woo Park, MD marketed Antithrombotic agents (antiplatelet and/or anticoagulant)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antithrombotic Agent class)

  1. Oslo University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Antithrombotic Agent — Competitive Intelligence Brief. https://druglandscape.com/ci/antithrombotic-agent. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: